CH 150: RN given refers to parent cpd; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 93406 |
CHEMBL ID | 1192318 |
SCHEMBL ID | 10941289 |
MeSH ID | M0133115 |
Synonym |
---|
ch 150 |
ch-150 , |
70381-44-1 |
3-ethyl-2,6-dimethyl-4h-pyrido(1,2-a)pyrimidin-4-one |
3-ethyl-2,6-dimethylpyrido[1,2-a]pyrimidin-4-one |
CHEMBL1192318 |
4h-pyrido(1,2-a)pyrimidin-4-one, 3-ethyl-2,6-dimethyl- |
RCSYPYSJSNRLSK-UHFFFAOYSA-N |
ch150 |
3-ethyl-2,6-dimethyl-4-oxo-4h-pyrido(1,2-a)pyrimidine |
2,6-dimethyl-3-ethyl-4-oxo-4h-pyrido[1,2-a]pyrimidine |
2,6-dimethyl-3-ethyl-4-oxo-4h-pyrido(1,2-a)pyrimidine |
AKOS024286601 |
SCHEMBL10941289 |
DTXSID60990574 |
3-ethyl-2,6-dimethyl-4h-pyrido[1,2-a]pyrimidin-4-one |
STARBLD0006423 |
PD160425 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (40.75) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |